Physical Medicine & Rehabilitation Doctors in Delaware Medicare Details, Address, Contact
85 Physical Medicine & Rehabilitation doctors found. Showing 21 - 40
 Nancy Kim, MD Physical Medicine & Rehabilitation - Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 4735 Ogletown-stanton Rd, Suite 3302, Newark, DE 19713 Phone: 302-623-4144 Fax: 602-623-4147 |
 Mr. David Scott Logerstedt, PT Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 053 Mckinley Lab, Newark, DE 19716 Phone: 302-831-8893 |
Chaya Divya Rajeev, Physical Medicine & Rehabilitation - Sports Medicine Medicare: Not Enrolled in Medicare Practice Location: 540 S College Ave Ste 160, Newark, DE 19713 Phone: 302-831-8893 |
James G Moran, DO Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 4102 Ogletown Stanton Rd Ste B, Newark, DE 19713 Phone: 302-731-2888 Fax: 301-731-7049 |
Ms. Laura Schmitt, PT, MS, SCS, ATC Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 120 W Park Pl, Newark, DE 19711 Phone: 302-738-0979 |
Anthony Rowe Cucuzzella, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 4735 Ogletown-stanton Rd, Suite 3302, Newark, DE 19713 Phone: 302-623-4144 Fax: 302-623-4147 |
Toran Drue Macleod, PT Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 63 E Delaware Ave, 053 Mckinly Lab, Newark, DE 19716 Phone: 302-831-8420 Fax: 302-831-4468 |
Dr. George Mark Bohatiuk, MD Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 500 Christiana Medical Ctr, Newark, DE 19702 Phone: 302-455-1007 |
Dr. Paula Richley Geigle, PT, PHD Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 053 Mckinly Lab, Newark, DE 19711 Phone: 302-831-8893 |
Kelly S Eschbach, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 4735 Ogletown-stanton Rd, Ste 2210, Newark, DE 19713 Phone: 302-623-4144 Fax: 302-623-4147 |
Elva Grace Delport, MKD Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 4735 Ogletown-stanton Rd, Suite 2210, Newark, DE 19713 Phone: 302-623-4144 Fax: 302-623-4147 |
Dr. Karin Gravare Silbernagel, PHD, PT, ATC Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 053 Mckinley Lab, Newark, DE 19716 Phone: 302-831-8893 |
Donald R. Archer Jr., MD Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 4735 Ogletown Stanton Rd, Ste 2210, Newark, DE 19713 Phone: 302-623-4144 Fax: 302-623-4147 |
Dr. Scott Thomas Roberts, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 4735 Ogletown Stanton Rd, Map 2, Suite 3302, Newark, DE 19713 Phone: 302-623-4144 |
Craig Sternberg, M.D. Physical Medicine & Rehabilitation - Sports Medicine Medicare: Accepting Medicare Assignments Practice Location: 87b Omega Dr, Newark, DE 19713 Phone: 302-733-0980 Fax: 302-733-7495 |
Dr. Andrew David Lynch, PT, DPT Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 053 Mckinly Lab, University Of Delaware, Newark, DE 19716 Phone: 302-831-8893 |
Ann Kim, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 4745 Ogletown Stanton Rd, Suite 3302, Newark, DE 19713 Phone: 302-623-4144 |
Adam Marc Ginsberg, D.O. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 4102 Ogletown Stanton Rd Ste B, Newark, DE 19713 Phone: 302-731-2888 Fax: 302-731-7049 |
Jonathan Edward Fass, PT, DPT Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 053 Mckinly Lab, Newark, DE 19716 Phone: 302-831-8893 |
Dr. Anthony Carroll, PT, DPT, CSCS Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 063 East Delaware Ave, 053 Mckinly Lab, Newark, DE 19716 Phone: 302-831-8893 |
News Archive
Iroko Cardio International Sàrl announces data on HDB dosing of tirofiban, abciximab in interventional cardiology
Iroko Cardio International Sàrl announces long-term, three-year, mortality data from the Phase III, open label, multi-national study comparing high-dose bolus (HDB) dosing of AGGRASTAT(tirofiban) (25mcg/kg bolus followed by a 0.15mcg/kg/min infusion for 18-24 hours) vs. ReoPro (abciximab) in patients undergoing primary percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI), presented at the 2010 European Society of Cardiology Meeting in Stockholm, Sweden.
Report examines African government funding for child development
Tanzania, Mozambique and Niger spend the most on child wellbeing in Africa - with Sudan, Angola and Burundi at the bottom of the table," according to an African Child Policy Forum report, which was launched in Addis Ababa, Ethiopia, on Tuesday at the opening of the Fourth International Policy Conference on the African Child, Deutsche Presse-Agentur/M&C reports (12/7).
Cardiac regeneration strategies need to be based on severity of heart injury
A new study by researchers at Children's Hospital Los Angeles has shown that neonatal mouse hearts have varying regenerative capacities depending upon the severity of injury. Using cryoinjury - damaging the heart through exposure to extreme cold in order to mimic cellular injury caused by myocardial infarction - investigators found that neonatal mouse hearts can fully recover normal function following a mild injury, though fail to regenerate after a severe injury.
NIH study finds limited kidney benefit from more rigorous blood pressure treatment
Using two drugs was no more effective than a single drug in slowing disease progression in people with autosomal dominant polycystic kidney disease (ADPKD), according to two studies funded by the National Institutes of Health. One of the studies also showed that rigorous blood pressure treatment slowed growth of kidney cysts, a marker of ADPKD, but had little effect on kidney function compared to standard blood pressure treatment.
NanoString introduces new assay for leukemia fusion gene analysis
NanoString Technologies, Inc., a privately held provider of life science tools for translational research and developer of molecular diagnostics, today announced the availability of a comprehensive multiplexed assay for the simple and cost-effective analysis of fusion genes linked to leukemia.
› Verified 5 days ago